Alzheimer's disease is a progressive neurodegenerative disorder that is pathologically characterized by the cerebral deposition of 39-42 amino acid peptides, termed β-amyloid (Aβ) 1 (1 PS1 encodes a hydrophobic protein with 467 amino acids spanning the membrane 6-8 times (10,11). Shortly after being synthesized, PS1 undergoes endoproteolytic cleavage by unknown proteases (named presenilinases) between transmembrane domains 6 and 7 to generate a 27kDa N-terminal fragment (NTF) and a 17kDa C-terminal fragment (CTF) (12). Cell biological studies indicated that full-length PS1 resides almost exclusively in the endoplasmic reticulum (ER) while the NTF and CTF localize predominantly in the Golgi and, to a lesser extent, in the plasma membrane and endocytic compartments (13-15). Endoproteolytic cleavage of PS1 is suggested to take place in the ER and the cleaved fragments are subsequently transported to the Golgi compartments (16). The subcellular location of the γ-secretase activity has been proposed to include multiple organelles such as the ER (17-20), late-Golgi/TGN (19,21), endosomes (17,20) and plasma membrane (15).
precursor protein (APP), a type 1 transmembrane glycoprotein that predominantly resides in the trans-Golgi Network (TGN), by two distinct enzymatic activities known as β-secretase (or BACE) and γ-secretase (2). Mutations of presenilins (presenilin 1, PS1 and presenilin 2, PS2) are responsible for the majority of early-onset familial Alzheimer's disease. Several lines of evidence suggest that PSs play a crucial role in intramembranous γ-secretase cleavage of select type I membrane proteins including APP and the signaling receptor, Notch-1 (3) (4) (5) (6) (7) (8) (9) .
PS1 encodes a hydrophobic protein with 467 amino acids spanning the membrane 6-8 times (10, 11) . Shortly after being synthesized, PS1 undergoes endoproteolytic cleavage by unknown proteases (named presenilinases) between transmembrane domains 6 and 7 to generate a 27kDa N-terminal fragment (NTF) and a 17kDa C-terminal fragment (CTF) (12) . Cell biological studies indicated that full-length PS1 resides almost exclusively in the endoplasmic reticulum (ER) while the NTF and CTF localize predominantly in the Golgi and, to a lesser extent, in the plasma membrane and endocytic compartments (13) (14) (15) . Endoproteolytic cleavage of PS1 is suggested to take place in the ER and the cleaved fragments are subsequently transported to the Golgi compartments (16) . The subcellular location of the γ-secretase activity has been proposed to include multiple organelles such as the ER (17) (18) (19) (20) , late-Golgi/TGN (19, 21) , endosomes (17, 20) and plasma membrane (15) .
While full-length PS1 has a rapid turnover rate, the NTF and CTF stably
EXPERIMENTAL PROCEDURES
Cell Cultures-Mouse neuroblastoma (N2a) cells were maintained in 1:1 Dulbecco's modified Eagle's media and OptiMEM supplemented with 5% fetal bovine serum (Invitrogen). Dulbecco's modified Eagle's media supplemented with 10% fetal bovine serum was used for CHO and HeLa cell cultures.
cDNA Constructs and Transfections----Full length human pen-2 was amplified by PCR from I.M.A.G.E. clone 3901082. Expression construct was generated by inserting full-length cDNA in frame with HA in pRK5 (Genetech) at the amino-terminus of PEN-2. Since inactivation of APH-1b only subtly reduces PS fragments in HeLa cells (33) , we mainly focused on APH-1a in current study. mAPH-1a L -Myc/His was described previously (33) . Nicastrin and presenilin expression constructs were described previously (26) . Transient transfections were performed using FuGENE6 transfection reagent (Roche). Co-expression of multiple cDNA constructs was achieved by co-transfection of equal amount of DNA, resulting in comparable levels of protein expression. Subcellular Fractionation--For subcellular fractionation, cells were homogenized using a ball-bearing cell cracker and cell lysates were fractionated using sucrose density gradient as described (19, 36) .
RNA interference, RNA extraction and RT-PCR---

RESULTS AND DISCUSSION
To investigate biological functions of endogenous mammalian PEN-2, polyclonal antibodies against the N terminus (PNT2) or C terminus (CR8) of mammalian PEN-2 were generated. Western blots analysis of N2a cell lysates revealed that the PEN-2 antibody CR8 detected a polypeptide of ~12kD, which is the predicted molecular weight of PEN-2. The antibody also recognized exogenous HA-PEN-2 that has a higher molecular weight due to the presence of the HA tag. The specificity of the antibody was further tested by immunoprecipitation. Significant amounts of endogenous PEN-2 were precipitated by CR8 but not by the pre-immune serum (Fig. 1A) . Consistent with the previous report (32) , the level of endogenous PEN-2 is largely decreased in PS1/PS2 double knockout embryonic stem cells (Fig. 1B) , further confirming that the 12 kD band detected by CR8 antibody is indeed endogenous PEN-2.
As predicted from the primary amino acid sequence, PEN-2 is an integral membrane protein as detected only in the membrane-enriched fractions resulted from 10,000 g and 100,000 g sedimentation (Fig. 1C) . As expected, subcellular fractionation studies using a well-established sucrose gradient (21, 39) revealed that endogenous PEN-and to rule out the possibility that binding of the C-terminal PEN-2 antibody could have interfered with the association of PS1 fragments with PEN-2, another PEN-2 antibody raised against the N-terminus, PNT2, was also used in co-immuniprecipitation studies of N2a cells (data not shown) and mouse brain homogenates. As shown in Fig. 2B , both PEN-2 antibodies failed to co-immunoprecipitate appreciable levels of PS1 CTF from mouse brain homogenates. In contrast, significant amounts of PS1 CTF were clearly immunoprecipitated by APH-1aL antibody H2D2 (33) from N2a cells ( Fig. 2A ) and mouse brain (Fig. 2B ).
The absence of readily detectable association between PS1 fragments and PEN-2 in co-immunoprecipitation studies led us to hypothesize that the interaction between PEN-2 and PS1 complex may be mediated via full-length PS1. Since the levels of endogenous full-length PS1 are extremely low in N2a cells, stably transfected cells overexpressing human PS1 were used for co-immunoprecipitation analyses. Similar to what was observed in naïve N2a cells, anti-PEN-2 antibody failed to precipitate the fragments of PS1. However, a substantial amount of full-length PS1 was coimmunoprecipitated by PEN-2 antibody but not the pre-immune serum (Fig. 2C ). These findings demonstrate that PEN-2 binds preferentially to full-length PS1, supporting our hypothesis that the interaction of PEN-2 with PS1 complex is mainly through its association with full-length PS1.
Previous studies have proposed that endoproteolysis of full-length PS1, required for the formation of the active and stable PS/γ-secretase complex, is faciliated by cellular factors available at limiting levels (23, 24) . Our observation of robust interaction between PEN-2 and full-length PS1 prompted us to examine whether PEN-2 is a potential factor mediating PS1 proteolytic processing. To this end, we inhibited endogenous PEN-2 and APH-1a expression in N2a cells by siRNA (see Experimental Procedures). The diminution of endogenous PEN-2 and APH-1a mRNA by siRNA was confirmed by RT-PCR ( Fig. 3A and B) and Northern blot analyses (data not shown). Consistent with earlier studies using Drosophila S2, HEK293 and HeLa cells (30-33), down-regulation of APH1a expression caused a reduction in the levels of PS1 fragments (CTF) in N2a cells (Fig.   3A) . On the other hand, down-regulation of PEN-2 expression led to a significant accumulation of full-length PS1 and concomitant decrease in the levels of processed PS1 derivatives. A similar effect of PEN-2 siRNA was observed in HeLa cells (Fig. 3A) .
The reduction of PS1 fragments may be attributed to either instability of the existing PS1 complex or a failure in de novo generation of the fragments or a combination of both. In the case of PEN-2 siRNA transfected cells, judging from the inverse relationship between the levels of PS1 holoprotein and processed fragments, the most likely explanation is that the reduced level of PS1 fragments resulted from a failure in their de novo generation by endoproteolysis of nascent PS1 holoprotein. Thus our findings from studies of RNA interference together with interaction between full-length PS1 and PEN-2 strongly suggest a role for PEN-2 in mediating the endoproteolysis of PS1.
It has been found that newly synthesized full-length PS1 peptides are rapidly endoproteolytically cleaved into fragments and excess full-length PS1 in transfected cells that fail to be converted to fragments is rapidly degraded (23) . To explore if the accumulation of full-length PS1 in PEN-2 siRNA transfected cells is due to its stabilization, we followed the decay of full-length PS1 in the presence of the protein synthesis inhibitor, cycloheximide, because pulse-chase analysis is ineffective when applied to presenilin processing or half-life (see ref 22 for detailed discussion). In agreement with previous reports (23, 24) , in control cells the levels of full-length PS1 are quite low and decline rapidly (within 2 hrs of cycloheximide treatment) while PS1 fragments (CTF) were more abundant and long-lived (Fig. 3B) , supporting the notion that full-length PS1 readily enters the cleavage pathway. In cells where the endogenous PEN-2 was eliminated by siRNA, the levels of accumulated full-length PS1 remained fairly unchanged for up to 8 hrs, indicating that endoproteolysis and/or degradation of fulllength PS1 are prevented in the absence of PEN-2. Given the fact that markedly lower levels of PS1 CTF are detected in PEN-2 siRNA transfected cells as compared with controls, and the remaining PS fragments were quite stable during the length of cycloheximide treatment (8 h) (Fig. 3B) , we conclude that accumulation of stabilized PS1 holoprotein and the concomitant diminution in the levels of PS1 fragment is a direct consequence of deficiency in endoproteolytic processing of PS1, further supporting our model that PEN-2 plays an indispensable role in the proteolytic cleavage of PS1.
Furthermore, these results also indicate that accumulated full-length PS1 resulting from endoproteolysis defect stays as a stable pool, which is resistant to the degradation machinery, providing further evidence for the notion that full length PS1 is stabilized by limiting cellular factors before endoproteolytic cleavage (23, 24) .
A recent study demonstrated that endogenous APH-1a associates with full-length PS1, suggesting a potential role of APH-1 in the maturation of PS1 complex (34) . Since APH-1 RNA interference does not result in the accumulation of full-length PS1 (Fig.   3A) , it is unlikely that APH-1 is directly involved in the cleavage step. Thus, we explored the possibility that APH-1 might serve a role in the stabilization of full-length PS1. As described above, rapid conversion of endogenous full-length PS1 to fragments makes it inaccessible to examine the stability of endogenous full-length PS1. Therefore, we eliminated APH-1a expression in N2a cells in which full-length PS1 accumulated due to PEN-2 siRNA. Interestingly, accumulation of full-length PS1 resulting from downregulation of PEN-2 was alleviated by additional siRNA down-regulation of APH-1a (Fig. 3C) . These results suggest that APH-1 is a co-factor essential for stabilizing nascent full-length PS1 and in the absence of APH-1, PS1 holoprotein is diverted to a rapid protein degradation pathway (24) rather than the endoprocessing pathway, which generates PS1 NTF and CTF. Nevertheless, these results do not formally rule out the possibility that APH-1 may also be involved in stabilizing PS1 fragments.
To confirm the results obtained from RNA interference experiments, we overexpressed PEN-2 and/or APH-1a in CHO cells with or without co-expression of human PS1. As expected, endogenous PS1 NTF level was increased after overexpression of PEN-2 or co-expression with APH-1a (Fig. 4, lane1, 2 and 4) . Notably, overexpression of APH-1a alone did not increase the fragment level (Fig.4, lane3 ). This could suggest that APH-1a is not a limiting factor mediating generation of PS1 fragments and that endogenous APH-1a alone is sufficient to stabilize PS1. The role of PEN-2 in endoproteolysis of exogenously expressed human PS1 was also revealed.
Overexpression of PS1 resulted in robust accumulation of full-length PS1 without noticeable increase in the level of PS1 NTF (Fig. 4, lane5 vs lane 1) , likely due to the paucity of limiting cellular factors necessary for PS1 endoproteolysis (23) . However, when PEN-2 was overexpressed, a fraction of full-length PS1 was converted to fragments (Fig. 4, lane 6) . In contrast, consistent with the endogenous PS1 results, overexpressing APH-1a had little effect on the levels of both full-length PS1 and its fragments (Fig.4,   lane 7) . When PEN-2 and APH-1a were co-expressed, full-length PS1 was efficiently cleaved into fragments (Fig.4, lane 8) . The further increase in PS1 NTF by APH-1 might be explained by the potential function of APH-1 in stabilizing PS1 fragments.
Based upon data presented in this study and those of other investigators, we propose that PEN-2 preferentially associates with full-length of PS1 and plays a crucial role in PS1 endoproteolytic cleavage. We further demonstrate that APH-1 is crucial for stabilizing PS1 and coordinates with PEN-2's function in endoproteolysis and the formation of PS1 fragments (which are widely believed to be the central elements of the γ-secretase complex). In summary, our data reveal a novel function of PEN-2 and APH-1 in mediating proteolytic cleavage of full-length PS1 and provide a cellular mechanism underlying the regulation by PEN-2 and APH-1 of γ-secretase activity, which governs Notch signaling pathways and the production of the amyloidogenic Aβ peptides. 
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